BRCA1 and cancer: The cancer risk associated with pathogenic BRCA1 variants peaks between 30 and 50 years [63], with a standardised incidence rate of 46.2 (37.3–57.1)% between the ages of 31 and 40 years compared to 7 (4.5–11)% in those between 61 and 70 years [62].